Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 2, 2012, Pages 353-360

  Yi, Tai ^a   Fogal, Birgit ^a,c   Hao, Zhengrong ^a   Tobiasova, Zuzana ^a   Wang, Chen ^a   Rao, Deepak A ^a,d   Al Lamki, Rafia S ^b   Kirkiles Smith, Nancy C ^a   Kulkarni, Sanjay ^a   Bradley, John R ^b   Bothwell, Alfred L M ^a   Sessa, William C ^a   Tellides, George ^a   Pober, Jordan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

graft arteriosclerosis; humanized arterial mouse model; hypoxia; reperfusion injury; transplantation

Indexed keywords

ADAPTIVE IMMUNITY; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA GRAFT; ARTERY WALL; ARTICLE; CARDIAC GRAFT REJECTION; CHIMERA; CONTROLLED STUDY; EX VIVO STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RNA ANALYSIS; T LYMPHOCYTE; ULTRASOUND;

ADAPTIVE IMMUNITY; ADULT; ANIMALS; ARTERIES; CHIMERA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MICE; MICE, SCID; MODELS, ANIMAL; REPERFUSION INJURY; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856165858     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.239285     Document Type: Article

References (32)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004;364:1814-1827.
2. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333:333-336.
3. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int. 2004;65: 713-718.
4. Libby P, Pober JS. Chronic rejection. Immunity. 2001;14:387-397.
5. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation. 1997;96:2069-2077.
6. Lietz K, Miller LW. Current understanding and management of allograft vasculopathy. Semin Thorac Cardiovasc Surg. 2004;16:386-394.
7. Li C, Yang CW. The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol. 2009;5:513-519.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and-independent factors influence chronic allograft rejection. Transplantation. 1995;59: 313-318.
9. Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfield SM. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc. 1997;29: 79-81.
10. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis: evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 1991;138:791-798.
11. Hagemeijer MC, van Oosterhout MF, van Wichen DF, van Kuik J, Siera-de Koning E, Gmelig Meyling FH, Schipper ME, de Jonge N, de Weger RA. T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population. Am J Transplant. 2008;8:1040-1050.
12. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS. Interferon-Γ elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207-211.
13. Chalasani G, Li Q, Konieczny BT, Smith-Diggs L, Wrobel B, Dai Z, Perkins DL, Baddoura FK, Lakkis FG. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol. 2004;172:7813-7820.
14. Gao X, Zhang H, Belmadani S, Wu J, Xu X, Elford H, Potter BJ, Zhang C. Role of TNF-α-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am J Physiol Heart Circ Physiol. 2008;295:H2242- H2249.
15. Linder N, Rapola J, Raivio KO. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest. 1999;79: 967-974.
16. Shiao SL, McNiff JM, Pober JS. Memory T cells and their costimulators in human allograft injury. J Immunol. 2005;175:4886-4896.
17. Kreisel D, Krasinskas AM, Krupnick AS, Gelman AE, Balsara KR, Popma SH, Riha M, Rosengard AM, Turka LA, Rosengard BR. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol. 2004;173:3027-3034.
18. Krupnick AS, Gelman AE, Barchet W, Richardson S, Kreisel FH, Turka LA, Colonna M, Patterson GA, Kreisel D. Murine vascular endothelium activates and induces the generation of allogeneic CD4+ 25+ Foxp3+ regulatory T cells. J Immunol. 2005;175:6265-6270.
19. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003;111:1819-1821.
20. Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, Tary-Lehmann M. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol. 1999;163:2267-2275.
21. Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS. Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol. 2007;179:4397-4404.
22. Lorber MI, Wilson JH, Robert ME, Schechner JS, Kirkiles N, Qian HY, Askenase PW, Tellides G, Pober JS. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation. 1999;67: 897-903.
23. Wang Y, Burns WR, Tang PC, Yi T, Schechner JS, Zerwes HG, Sessa WC, Lorber MI, Pober JS, Tellides G. Interferon-γ plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J. 2004;18:606-608.
24. Yacoub-Youssef H, Marcheix B, Calise D, Thiers JC, Benoist H, Blaes N, Segui, Dambrin C, Thomsen M. Use of human mesenteric arteries to study chronic vascular rejection in SCID/beige mice reconstituted with human spleen cells. Transplant Proc. 2005;37:75-76.
25. Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, Schiopu A, Taggart DP, Wood KJ. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med. 2010;16:809-813.
26. Abele-Ohl S, Leis M, Mahmoudian S, Weyand M, Stamminger T, Ensminger SM. Rag2-/-γ-chain-/-mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution. Transpl Immunol. 2010;23:59-64.
27. Schaper J, Hehrlein F, Schlepper M, Thiedemann KU. Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery. J Mol Cell Cardiol. 1977;9:175-189.
28. Murray AG, Libby P, Pober JS. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol. 1995;154:151-161.
29. Zhang P, Manes TD, Pober JS, Tellides G. Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells. Arterioscler Thromb Vasc Biol. 2010;30:1795-1801.
30. Zhao XM, Hu Y, Miller GG, Mitchell RN, Libby P. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts. Circulation. 2001;103:525-531.
31. Gee JM, Kalil A, Shea C, Becker KJ. Lymphocytes: potential mediators of post-ischemic injury and neuroprotection. Stroke. 2007;38(2 suppl): 783-788.
32. Liao YH, Cheng X. Autoimuunity in myocardial infarction. Int J Cardiol. 2006;112:21-26.